We next compared the effect of the topoisomerase I (TOP1) inhibitor camptothecin (CPT) on ATAC-seq patterns in human leukemia CCRF-CEM (SLFN11-positive) cells and their isogenic SFLN11-knockout [31]. This evidence concerns the gene TOP1 and leukemia.